IL17A and psoriasis: In summary, our growing understanding of the IL-17 cytokine family helps us to better understand the pathophysiology of psoriasis as well as the distinct profiles of numerous drugs either already approved or in advanced stages of clinical development for this indication with regard to efficacy, mode of onset, and safety.